ICD-10-CM Billable Code

F19.23

Other psychoactive substance dependence with withdrawal

Clinical Classification Guidelines

Excludes Type 1

  • other psychoactive substance dependence with intoxication (F19.22-)

Medical Intelligence & Overview

ICD-10 code F19.23 refers to a condition characterized by dependence on psychoactive substances, where the individual experiences significant withdrawal symptoms upon cessation or reduction. Psychoactive substances include medications and drugs that affect the brain's functioning, leading to altered mood, perception, or consciousness. Dependence indicates a physical or psychological need for the substance, often accompanied by withdrawal symptoms if the substance use is abruptly stopped or reduced. This condition is a serious health concern that requires comprehensive management to address both the dependence and the withdrawal effects.

Causes & Symptoms

Clinical Causes: Chronic use of psychoactive substances such as opioids, sedatives, stimulants, or hallucinogens Repeated exposure leading to neurochemical changes in the brain resulting in dependence Environmental and psychological factors including stress, peer pressure, and mental health disorders Genetic predispositions that increase susceptibility to substance dependence Inadequate access to addiction treatment resources or support systems

Key Symptoms: Intense cravings for the substance Withdrawal symptoms like sweating, tremors, nausea, or anxiety when not using the substance Persistent desire or unsuccessful efforts to cut down or control use Changes in behavior such as secrecy, neglect of responsibilities, or social withdrawal Physical symptoms including headaches, fatigue, or gastrointestinal discomfort during withdrawal Psychological issues such as irritability, depression, or sleep disturbances

Diagnostic & Treatment

Diagnosis Path: Diagnosing this condition involves a comprehensive evaluation by a healthcare professional, including a detailed medical history and physical examination. Diagnostic criteria focus on the pattern of substance use, evidence of dependence, and the presence of withdrawal symptoms. Standardized questionnaires and laboratory tests can support the assessment. Clinicians examine if the individual has experienced compulsive use, difficulty stopping despite negative consequences, and physical or psychological withdrawal signs. The diagnosis aligns with the guidelines outlined in the ICD-10 classification system for substance dependence.

Treatment Protocols: Treatment strategies typically involve a combination of medical, psychological, and social interventions. Approaches include: - **Detoxification:** Safely managing withdrawal symptoms under medical supervision - **Medication-assisted treatment:** Using approved medications to reduce cravings and withdrawal severity - **Psychotherapy:** Engagement in counseling or behavioral therapies such as cognitive-behavioral therapy (CBT) or motivational interviewing - **Support groups:** Participation in community or peer support programs - **Addressing underlying mental health issues:** Treating concurrent psychological conditions that may contribute to substance use Successful management emphasizes a multidisciplinary approach tailored to the individual's needs, aiming to achieve long-term abstinence and improve quality of life.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F19.23 a billable ICD-10 code?
Yes, F19.23 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F19.23?
Clinical documentation must specify the nature of Other psychoactive substance dependence with withdrawal and any associated comorbidities for accurate reporting.

Cite this Clinical Reference